CHRS
Coherus BioSciences Inc
1.10$
-3.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | +443.6% | -124.3% | – | – | – | – | |
| – | +177.3% | +60.3% | +13.4% | -4.8% | +0.7% | -11.4% | +19.6% | +7.1% | +2.5% | +39.2% | -25.6% | |
| – | +51.2% | +64.0% | +31.5% | -3.5% | -3.5% | +13.6% | +34.6% | -1.2% | -15.0% | -35.5% | -39.0% | |
| – | -26.2% | +34.2% | +27.7% | -7.4% | -3.6% | +11.7% | +554.3% | -66.8% | – | – | – | |
| – | +220.4% | -274.7% | – | – | -1,206.4% | – | – | -287.1% | – | – | -110.5% | |
| – | +116.4% | +5.7% | -29.8% | -82.7% | +1,534.6% | -43.9% | -82.2% | +58.2% | -86.0% | -100.0% | – | |
| – | +1,223.6% | -6.2% | -32.2% | -73.1% | +971.7% | +13.1% | +861.1% | +20.5% | – | +59.2% | +62.9% | |
| – | – | – | – | – | – | -71.8% | -91.4% | +113.6% | – | – | – | |
| – | – | -77.2% | -120.9% | – | -122.2% | +8.0% | +99.2% | +113.6% | -4.2% | – | – | |
| – | +0.0% | +0.0% | -27.0% | +0.0% | +0.0% | +204.5% | -100.3% | – | -100.0% | – | +25.7% | |
| – | -9.8% | +84.4% | -8.6% | -49.0% | -15.2% | +150.6% | -76.8% | +4.7% | +28.1% | -368.6% | +46.4% | |
| – | -92.9% | -524.8% | – | -2,878.3% | – | +247.3% | -134.1% | – | – | -41.8% | -262.1% | |
| – | – | – | – | – | – | +850.4% | -126.4% | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.